Phase II Clinical Trial of Alisertib, an Aurora a Kinase Inhibitor, in Combination with Induction Chemotherapy in High-Risk, Untreated Patients with Acute Myeloid Leukemia
Year: 2018
Type: conference-abstract
Source: Blood
Authors: Andrew M. Brunner, Traci M. Blonquist, Daniel J. DeAngelo, Malgorzata McMasters, Eric S. Winer, Gabriela S. Hobbs, Philip C. Amrein, Hanno Hock, David P. Steensma, Jacqueline S. Garcia, Marlise R. Luskin, Richard M. Stone, Karen K. Ballen, Jacalyn Rosenblatt, David E. Avigan, Steven L McAfee, Jenna A. Moran, Meghan Bergeron, Julia Foster, Christina Bertoli, Kristin McGregor, Kaitlyn Fishman, Molly Macrae, Meghan Burke, Tanya T. Behnan, Tina T. Som, Aura Y. Ramos, Megan K. Vartanian, Nicole Nelson, Emma Logan, Jennifer Lombardi Story, Christine Connolly, Donna S Neuberg, Yi-Bin Chen, Timothy A. Graubert, Amir T. Fathi
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2907347080